拓新药业子公司精泉生物取得药品生产许可证

Core Viewpoint - The company has successfully obtained a drug production license from the Henan Provincial Drug Administration for its subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd, indicating that its coenzyme Q10 raw material products are now compliant for production [1] Group 1 - The license acquisition marks a significant milestone for the company, allowing it to produce coenzyme Q10 related products legally [1] - The approval enhances the company's production capabilities and positions it favorably in the market for coenzyme Q10 [1]